Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"CBL- Chemical and Biopharmaceutical Laboratories","sponsor":"Relaxera Pharmazeutische","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Relaxera and CBL Patras Announce Exclusive Agreement on Manufacturing and Sales of Synthetic Human Relaxin-2","therapeuticArea":"Cardiology\/Vascular Diseases","highestDevelopmentStatus":"Phase II","country":"GREECE","productType":"Peptide","productStatus":"New Molecular Entity","date":"December 2020","url1":"","url2":"","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase II"}]

    Find Clinical Drug Pipeline Developments & Deals by CBL- Chemical and Biopharmaceutical Laboratories

    Menu

    CBL- Chemical and Biopharmaceutical Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              CBL- Chemical and Biopharmaceutical Laboratories

              Contact Supplier
              • Deals
              Virtual BoothCBL is an ideal partner for outsourcing your Peptide manufacturing needs.
              Contact Supplier Contact Supplier
              Flag Greece
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Relaxera and CBL Patras Announce Exclusive Agreement on Manufacturing and Sales of Synthetic Human Relaxin-2

              Details:

              This cooperation agreement designates CBL as the exclusive manufacturing partner for synthetic human relaxin-2 (GMP and non-GMP) and Relaxera as the exclusive sales executive partner for relaxin.

              Lead Product(s): Relaxin-2 protein, human

              Therapeutic Area: Cardiology/Vascular Diseases Product Name: Undisclosed

              Highest Development Status: Phase II Product Type: Peptide

              Recipient: Relaxera Pharmazeutische

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership December 16, 2020

              CBL Company Banner

              Iran Expo

              Not Confirmed

              envelop Contact Supplier
              CBL VB RM
              Send me more info on How To Grow My Business Digitally?
              Post Enquiry
              POST ENQUIRY